Mucormycosis and COVID 19: From the desk of a periodontist
Oral mucormycosis is not a new disease and is known to occur in patients with low immunity such as in uncontrolled diabetes, posttransplant, and some cancer treatments. A sudden surge has been reported in mucormycosis in cases with COVID-19. Although rare, serious complication of COVID-19. The aim o...
Saved in:
Main Author: | Malvika Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-01-01
|
Series: | Apollo Medicine |
Subjects: | |
Online Access: | http://www.apollomedicine.org/article.asp?issn=0976-0016;year=2021;volume=18;issue=3;spage=184;epage=186;aulast=Singh |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Osteoarticular mucormycosis of the distal femur in a post COVID-19 patient
by: Srinivas Kasha, et al.
Published: (2024-12-01) -
Oral Manifestations, Risk Factors and Management Strategies of COVID-19 Associated Mucormycosis in Tertiary Care Hospital
by: Pankaj Goel, et al.
Published: (2023-04-01) -
COVID-19–associated central nervous system mucormycosis
by: Anjali Mishra, et al.
Published: (2021-01-01) -
Pulmonary Mucormycosis – An Experience from a Tertiary Care Center in Southern India: A PULM MUCOR Study
by: Ashwin Oliver Arul, et al.
Published: (2025-01-01) -
Post-COVID Mucormycosis: An Emerging Threat in Developing Countries - A Prospective Review
by: Debpratim Chakraborty, et al.
Published: (2024-11-01)